Mixed Phenotype Acute Leukemia — Trials

Mixed Phenotype Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

96 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 29
Ph III recruiting: 2
Growth YoY: —
Industry share: 17%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07346105	Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies	available	—	—	Orca Biosystems, Inc.INDUSTRY	1	Sep 21, 2026	clinicaltrials

Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials